Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...

Scientists in Spain say they have uncovered a cure for pancreatic cancer in mice. The breakthrough could help people ...

Pancreatic cancer has long been one of the most lethal diagnoses in medicine, largely because it spreads early and hides from ...

The biochemist’s company, Vega Oncotargets, has toned down its message after the false expectations generated by the ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical ...

A team of researchers at the Georgetown University Lombardi Comprehensive Cancer Center published new research exploring causes and potential treatment methods for pancreatic ...

ABC News' Becky Worley got an inside look at the Baylor College of Medicine in Houston, Texas, where researchers are making progress in treating one of the deadliest forms of cancer.

Researchers in Spain have developed a therapy protocol that could revolutionize the treatment of pancreatic cancer.

Discover the latest advancements in pancreatic cancer treatment, including targeted therapies and next-generation sequencing, transforming patient care and outcomes.

On January 12, NP-G2-044 (Prilukae), a novel oral fascin inhibitor earned ODD for the treatment of pancreatic cancer. This designation covers the use of the agent as monotherapy and in combination ...

Researchers found that nerves and cancer-supporting cells team up early to drive pancreatic cancer—breaking that alliance could weaken the disease before it fully forms.

When scientists sequence tumor DNA, they typically find small amounts of genetic code from bacteria, viruses and fungi – microorganisms that, if actually present in tumor tissues, could influence how ...